摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

烯丙基月桂酸酯 | 7003-75-0

中文名称
烯丙基月桂酸酯
中文别名
——
英文名称
allyl dodecanoate
英文别名
allyl laurate;lauric acid allyl ester;Laurinsaeure-allylester;Allyllaurat;prop-2-enyl dodecanoate
烯丙基月桂酸酯化学式
CAS
7003-75-0
化学式
C15H28O2
mdl
MFCD00048428
分子量
240.386
InChiKey
ZQMAPKVSTSACQB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    135-136°C 4,5mm

计算性质

  • 辛醇/水分配系数(LogP):
    5.9
  • 重原子数:
    17
  • 可旋转键数:
    13
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2915900090

SDS

SDS:139bb862d1dc310d0fe196b8fe968cc2
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    烯丙基月桂酸酯cethyltrimethylammonium permanganate 作用下, 以 二氯甲烷 为溶剂, 反应 5.0h, 以80%的产率得到甘油单月桂酸酯
    参考文献:
    名称:
    Gangadhar, A.; Subbarao, R.; Lakshminarayana, G., Synthetic Communications, 1989, vol. 19, # 13-14, p. 2505 - 2514
    摘要:
    DOI:
  • 作为产物:
    描述:
    月桂酸甲酯烯丙醇 在 tetracyanomethylene 作用下, 反应 48.0h, 以57%的产率得到烯丙基月桂酸酯
    参考文献:
    名称:
    四氰基乙烯和双氰基乙烯酮二甲基乙缩醛催化羧酸的温和酯化和酯交换反应
    摘要:
    发现 π 酸四氰基乙烯 (TCNE) 及其衍生物二氰基烯酮二甲基乙缩醛 (DCKDMA) 可催化月桂酸与各种醇的酯化反应。该方法成功地应用于多种羧酸的甲酯化,包括芳香族、α,β-不饱和、α-羟基和 N-Cbz 和 N-Boc 保护的 α-氨基酸,在室温至60℃。还发现 TCNE 在月桂酸甲酯的酯交换反应中用作催化剂。
    DOI:
    10.1246/cl.1997.55
点击查看最新优质反应信息

文献信息

  • AROMATIC AMINE COMPOUND, CURING AGENT FOR EPOXY COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING AROMATIC AMINE COMPOUND
    申请人:TOKYO OHKA KOGYO CO., LTD.
    公开号:US20210130284A1
    公开(公告)日:2021-05-06
    An aromatic amine compound capable of satisfactorily forming a cured product having exceptional alkali resistance by reaction with an epoxy compound; a curing agent for an epoxy compound, the curing agent including the aromatic amine compound; a curable composition including the curing agent for an epoxy compound; a cured product of the curable composition; a method for producing the cured product; and a method for producing the abovementioned aromatic amine compound. The aromatic amine compound has a structure such that a specific position in a central skeleton comprising a fused ring such as a fluorene ring is substituted with a side-chain group including two aromatic groups linked by a flexible bond such as an amide bond, at least one amino group is bonded to the end of the side-chain group, and the structure has no hydroxyl groups.
    一种芳香胺化合物,通过与环氧化合物反应能够满意地形成具有异常碱性抗性的固化产品;一种环氧化合物的固化剂,该固化剂包括芳香胺化合物;一种包括环氧化合物的固化剂的可固化组合物;可固化组合物的固化产品;生产所述固化产品的方法;以及生产上述芳香胺化合物的方法。该芳香胺化合物具有这样的结构,即中心骨架中的特定位置包括类似于芴环的融合环,该位置被取代为包括通过柔性键(如酰胺键)连接的两个芳香基的侧链基团,至少一个氨基固定在侧链基团的末端,并且该结构不含羟基。
  • Cobalt-Catalyzed Deprotection of Allyl Carboxylic Esters Induced by Hydrogen Atom Transfer
    作者:Nan Li、Yizhen Gui、Mengqi Chu、Mengdi You、Xiaohan Qiu、Hejia Liu、Shiang Wang、Meng Deng、Baoming Ji
    DOI:10.1021/acs.orglett.1c03185
    日期:2021.11.5
    A brief, efficient method has been developed for the removal of the allyl protecting group from allyl carboxylic esters using a Co(II)/TBHP/(Me2SiH)2O catalytic system. This facile strategy displays excellent chemoselectivity, functional group tolerance, and high yields. This transformation probably occurs through the hydrogen atom transfer process, and a Co(III)–six-membered cyclic intermediate is
    已经开发了一种使用 Co(II)/TBHP/(Me 2 SiH) 2 O 催化体系从烯丙基羧酸酯中去除烯丙基保护基的简短有效方法。这种简便的策略显示出优异的化学选择性、官能团耐受性和高产率。这种转变可能通过氢原子转移过程发生,推荐使用 Co(III)-六元环状中间体。
  • SUBSTITUTED OR UNSUBSTITUTED ALLYL GROUP-CONTAINING MALEIMIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION AND CURED PRODUCT USING SAID COMPOUND
    申请人:DIC CORPORATION
    公开号:US20200325101A1
    公开(公告)日:2020-10-15
    Bismaleimides (BMI) exhibit excellent heat resistance (high Tg and high resistance to thermal decomposition) compared to epoxy resins and phenolic resins, and therefore, in recent years, more attention is paid to bismaleimides as a resin material for the next-generation devices represented by SiC power semiconductors, in addition to the investigation on the use of bismaleimides for electronic material applications. As such, conventional BMI's are known as highly heat-resistant resins; however, there is a demand for a resin having higher heat resistance for advanced material applications and the like. Thus, an object of the invention is to provide a novel maleimide compound having superior heat resistance. Disclosed is a substituted or unsubstituted allyl group-containing maleimide compound having a structure with three or more benzene rings, having one or more groups each having a substituted or unsubstituted allyl group, and having one or more maleimide groups.
    亚苯基马来酰亚胺化合物,具有三个或更多苯环的结构,含有一个或多个取代或未取代的烯丙基团,以及一个或多个马来酰亚胺基团,具有卓越的耐热性。
  • personal care products incorporating cellulosic fatty acid esters
    申请人:Shelton Charles Michael
    公开号:US20060062749A1
    公开(公告)日:2006-03-23
    A personal care product composition containing a long chain fatty acid cellulose ester (LCCE) having a degree of substitution greater than about 1.0 of an ester substituent or residue from fatty acids having from 6 to 18 carbon atoms wherein the LCCE is soluble in at least one cosmetically acceptable solvent selected from the group consisting of hydrocarbons, alkyl esters, fats and oils, fatty acids, fatty alcohols, and silicone oils.
    一种个人护理产品组合物,包含具有取代度大约大于1.0的长链脂肪酸纤维素酯(LCCE),该酯基或残基来自具有6至18个碳原子的脂肪酸,其中LCCE可溶于至少一种从烃、烷基酯、脂肪和油脂、脂肪酸、脂肪醇和硅油等成分中选择的至少一种化妆品可接受的溶剂。
  • METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
    申请人:Stover Richard R.
    公开号:US20080175891A1
    公开(公告)日:2008-07-24
    The present invention provides transdermal administration of AICA riboside, or a prodrugs, analogs, or salts thereof, and/or a blood clotting inhibitor for preventing or reducing adverse side effects in a patient. The type of patient that may benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient undergoing non-vascular surgery, or a fetus during labor and delivery.
    本发明提供了通过经皮途径给予AICA核糖苷,或其前药、类似物或盐,和/或血液凝块抑制剂以预防或减少患者的不良副作用。可能受益的患者类型包括左心室功能减退的患者、先前发生心肌梗死的患者、接受非血管手术的患者,或分娩期间的胎儿。
查看更多